N-(2-fluoro-4-methylphenyl)-2-[3-(2-methylpyrazol-3-yl)-8-azabicyclo[3.2.1]oct-2-en-8-yl]propanamide
C21H25FN4O — CID 155944708
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-fluoro-4-methylphenyl)-2-[3-(2-methylpyrazol-3-yl)-8-azabicyclo[3.2.1]oct-2-en-8-yl]propanamide
N-(2-fluoro-4-methylphenyl)-2-[3-(2-methylpyrazol-3-yl)-8-azabicyclo[3.2.1]oct-2-en-8-yl]propanamide (PubChem CID 155944708) has the molecular formula C21H25FN4O and a molecular weight of 368.46 g/mol. Its IUPAC name is N-(2-fluoro-4-methylphenyl)-2-[3-(2-methylpyrazol-3-yl)-8-azabicyclo[3.2.1]oct-2-en-8-yl]propanamide.
Molecular Properties
| Compound Name | N-(2-fluoro-4-methylphenyl)-2-[3-(2-methylpyrazol-3-yl)-8-azabicyclo[3.2.1]oct-2-en-8-yl]propanamide |
|---|---|
| PubChem CID | 155944708 |
| Molecular Formula | C21H25FN4O |
| Molecular Weight | 368.46 g/mol |
| Exact Mass | 368.20 |
| IUPAC Name | N-(2-fluoro-4-methylphenyl)-2-[3-(2-methylpyrazol-3-yl)-8-azabicyclo[3.2.1]oct-2-en-8-yl]propanamide |
| SMILES | Cc1ccc(NC(=O)C(C)N2C3C=C(c4ccnn4C)CC2CC3)c(F)c1 |
| InChI | InChI=1S/C21H25FN4O/c1-13-4-7-19(18(22)10-13)24-21(27)14(2)26-16-5-6-17(26)12-15(11-16)20-8-9-23-25(20)3/h4,7-11,14,16-17H,5-6,12H2,1-3H3,(H,24,27) |
| InChIKey | BMLKYPCTZOGWLK-UHFFFAOYSA-N |
| XLogP | 3.51 |
| TPSA | 50.16 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 368.46 |
| LogP ≤ 5 | 3.51 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155944708 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.